# Ascension Ventures

> Ascension Ventures is a VC fund in Clarkton backing Health Care and Medical. See 112 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Clarkton, United States
- Total investments: 112
- Last investment: Jun 2026
- Lead investor: 29%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/ascension-media-group
- X (Twitter): http://twitter.com/AscensionHealth
- Website: http://ascensionventures.org/

Ascension Ventures is a VC fund in Clarkton focused on Health Care and Medical. AHV was established in 2001 by Ascension Health with a commitment of $125 million to invest in expansion- to late-stage healthcare companies. Ascension Health is the nation's largest Catholic and largest nonprofit health system serving patients through a network of hospitals and health facilities in 20 states and the District of Columbia. AHVoffers its limited partners the ability to earn venture-level financial returns while providing early insight to future healthcare developments.

## Contacts

5 contacts available for Ascension Ventures. Shizune tracks 7 team members at Ascension Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/ascension-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $4.8M–$23M |
| Series B | $7.1M–$105M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 49 | 44% |
| Medical | 25 | 22% |
| Medical Device | 25 | 22% |
| Biotechnology | 20 | 18% |
| Software | 14 | 13% |

86 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 19 | 17% |
| Series A | 17 | 15% |
| Funding Round | 17 | 15% |
| Series C | 16 | 14% |
| Series D | 14 | 13% |

13 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 57 | 51% |
| United Kingdom | 18 | 16% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Brendan Salvino | Senior Associate | 0 | https://shizune.co/investors/profile/brendan-salvino-6ae4 |
| Brian Belsky | Principal | 3 | https://shizune.co/investors/profile/brian-belsky-6be7 |
| Jamie Wehrung | Chief Administrative Officer | 0 | https://shizune.co/investors/profile/jamie-wehrung |
| John Kuelper | Co-Founder & CEO; Managing Director | 14 | https://shizune.co/investors/profile/john-kuelper |
| Matt Hermann | Senior Managing Director | 0 | https://shizune.co/investors/profile/matt-hermann |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Neuronostics | Neuronostics Ltd is a newly established University of Exeter (UK) spin-out, focussed on the development and commercialisation of a novel and potentially revolutionary seizure susceptibility assessment technology called #BioEP. | $4M | Seed | Jun 30, 2026 |  |
| Rejoni | Rejoni uses bio-materials to develop medical devices that improve the outcome of minimally invasive and gynecological surgical procedures. | $25M | Venture - Series Unknown | Jun 16, 2026 |  |
| Stream | Stream is a financial services firm that allows employees to stream their earned wages into their accounts through an instant app. The app allows them to have complete control over when they get paid. It also effectively ends the need for employee advances, loans, and employee stress suffered from short-term, unplanned financial obligations. Thecompany aims to play a key role in reducing the poverty premium and preventing employees from entering cycles of debt caused by overdraft fees, high-interest credit, or payday loans. | $90M | Series D | Jan 20, 2026 |  |
| TUAL Technology | TUAL Technology builds and deploys powerbanks and Pro-charging for EVs. | $2M | Seed | Jan 20, 2026 |  |
| Cofactor Genomics | Cofactor Genomics is a company focused on predictive immune modeling. They aim to advance precision medicine by overcoming existing barriers. Cofactor facilitates the shift from single-analyte biomarkers to more comprehensive multidimensional biomarkers using health expression models. Their capabilities include molecular, informatic, and databasetools, with one of the first CAP-certified clinical RNA sequencing laboratories. This certification helps their partners conduct clinical trials more efficiently and cost-effectively. Their expertise in molecular biology, informatics, and database management enables them to provide high-quality services to the healthcare and pharmaceutical sectors, contributing to medical research and improving patient outcomes. |  | Venture - Series Unknown | Dec 15, 2025 |  |
| NextSense | NextSense unlocks brain health with real-world data insights and practical, scientific wisdom for daily living. It aims to catalyze brain health in science and culture. The company was founded in 2020 and is headquartered in Mountain View, California. | $16.3M | Series A | Nov 11, 2025 |  |
| Cala Health | Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology. |  |  | Dec 09, 2024 |  |
| Cala Health | Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology. | $50M | Series C | Dec 09, 2024 |  |
| Tembo Money | Tembo is on a mission to transform lending. Its innovative mortgage product is helping generation buy a home | $17.8M | Series B | Nov 29, 2024 |  |
| Research Grid (R.grid) | R.grid has built machine learning-based software for medical research. | $6.4M | Seed | Nov 06, 2024 |  |

10 of 112 investments shown.

## Co-investors
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 9 deals together
- [SV Health Investors](https://shizune.co/investors/profile/sv-life-sciences) — VC Fund, 9 deals together
- [HLM Venture Partners](https://shizune.co/investors/profile/hlm-venture-partners) — VC Fund, 7 deals together
- [Catalyst Health Ventures](https://shizune.co/investors/profile/catalyst-health-ventures) — VC Fund, 6 deals together
- [Sparta Group](https://shizune.co/investors/profile/sparta-group-llc) — VC Fund, 6 deals together
- [AMED Ventures](https://shizune.co/investors/profile/amed-ventures) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [Adam Nash](https://shizune.co/investors/profile/adam-nash) — Angel Investor
- [Dream Maker Ventures (DMV)](https://shizune.co/investors/profile/dream-maker-ventures-dmv) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [Mobile Advertising Investors in United Kingdom](https://shizune.co/investors/mobile-advertising-investors-united-kingdom)
- [Mobile Advertising Investors](https://shizune.co/investors/mobile-advertising-investors)
- [Mobile Advertising VC Funds](https://shizune.co/investors/mobile-advertising-vc-funds)
- [Celebrity VC Funds](https://shizune.co/investors/celebrity-vc-funds)
- [Celebrity Investors in Europe](https://shizune.co/investors/celebrity-investors-europe)
- [Celebrity VC Funds in Europe](https://shizune.co/investors/celebrity-vc-funds-europe)

## FAQ

### What does Ascension Ventures invest in?

Ascension Ventures invests primarily in Health Care, Medical and Medical Device startups, most often at Series B and Series A stage. Most of the 112 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Ascension Ventures's check size?

Ascension Ventures typically joins rounds of $4.8M–$23M at Series A and $7.1M–$105M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ascension Ventures participates in.

### How do I contact Ascension Ventures?

Public channels for Ascension Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Ascension Ventures?

The team at Ascension Ventures includes Brendan Salvino (Senior Associate), Brian Belsky (Principal) and Jamie Wehrung (Chief Administrative Officer), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co